
KalVista Pharma (KALV)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy KalVista Pharma (KALV) Stock
Start investing in KalVista Pharma (KALV)
About KalVista Pharma (KALV)
Market cap | $644.31M |
Today's volume | 772.13K |
Revenue (TTM) | — |
Avg. daily volume | 594.64K |
EBITDA (TTM) | -$180.52M |
Open | $13 |
Price / earnings ratio | -3.48x |
Today's range | $12.84 - $13.37 |
Debt / equity | 73.52x |
52 week range | $7.3 - $15.5 |
5 year debt / equity | 3.3x |
Beta (LTM) | 0.97x |
Interest coverage | — |
Dividend & yield | $0.00 (0.00%) |
Current ratio | 10.44x |
Ex-dividend date | — |
Next earnings | Jul 10, 2025 |
Dividend payable date | — |
KalVista Pharma Stock Rating
KalVista Pharma Stock News
View all



Frequently Asked Questions (FAQ)
How to buy KALV stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in KALV stock
Navigate to the Explore page. Then, type KALV into the search bar. When you see KALV stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased KALV stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
KalVista Pharma Stock Earnings
The value each KALV share was expected to gain vs. the value that each KALV share actually gained.
KalVista Pharma (KALV) reported Q3 2025 earnings per share (EPS) of -$0.92, missing estimates of -$0.88 by 4.55%. In the same quarter last year, KalVista Pharma's earnings per share (EPS) was -$0.84. KalVista Pharma is expected to release next earnings on 07/10/2025, with an earnings per share (EPS) estimate of -$0.92.